[Effect of recombinant human growth hormone with total parenteral nutrition on albumin synthesis in patients with peritoneal sepsis].

What Was Tested

Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this controlled clinical trial publication.

To investigate the effect of recombinant human growth hormone (rhGH) in combination with total parenteral nutrition (TPN) on albumin synthesis in patients with peritoneal sepsis.

Who Took Part

The abstract describes 17 patients taking part.

The age groups tagged for this paper are teenagers, adults, middle-aged adults and older adults, both men and women.

17 patients with peritoneal sepsis were divided randomly into two groups.

The TPN scheme and other treatment were the same in the two groups.

How the Study Was Run

The design is described as randomized.

Random assignment meant chance, not the researchers, decided who got Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and who got the comparison, which limits bias.

What Was Measured

Topics PubMed links to this paper include Blood Proteins, Combined Modality Therapy, Human Growth Hormone, Parenteral Nutrition, Peritoneal Diseases, Prealbumin and Recombinant Proteins.

What This Means in Plain Language

The paper is a randomized study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 17 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Results are reported in around 2 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 1998 (Zhonghua wai ke za zhi [Chinese journal of surgery]), a journal based in China.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.